DOI QR코드

DOI QR Code

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

  • Ji Su Ko (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Jeong Hyun Lee (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Dok Hyun Yoon (Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Chong Hyun Suh (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Sae Rom Chung (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Young Jun Choi (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Jung Hwan Baek (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center)
  • Received : 2023.11.05
  • Accepted : 2024.01.11
  • Published : 2024.04.01

Abstract

Keywords

References

  1. Frey N, Porter D. Cytokine release syndrome with chimeric antigen receptor T cell therapy. Biol Blood Marrow Transplant 2019;25:e123-e127 https://doi.org/10.1016/j.bbmt.2018.12.756
  2. Wei J, Liu Y, Wang C, Zhang Y, Tong C, Dai G, et al. The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma. Signal Transduct Target Ther 2020;5:134
  3. Luan C, Zhou J, Wang H, Ma X, Long Z, Cheng X, et al. Case report: local cytokine release syndrome in an acute lymphoblastic leukemia patient after treatment with chimeric antigen receptor T-cell therapy: a possible model, literature review and perspective. Front Immunol 2021;12:707191
  4. Inoue Y, Fujino T, Chinen S, Niiyama-Uchibori Y, Ide D, Kawata M, et al. Cervical local cytokine release syndrome following chimeric antigen receptor T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma. Cureus 2023;15:e38905
  5. Shima H, Kurosawa T, Oikawa H, Kobayashi H, Nishi E, Yamazaki F, et al. Cervical edema extending to the larynx as local cytokine release syndrome following chimeric antigen receptor T-cell therapy in a boy with refractory acute lymphoblastic leukemia. Case Rep Oncol 2022;15:257-262 https://doi.org/10.1159/000522669
  6. Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan K, Muller-Tidow C, et al. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy. Ann Oncol 2021;32:34-48 https://doi.org/10.1016/j.annonc.2020.10.478
  7. Reiser V. Beyond CAR T-cell therapy: continued monitoring and management of complications. J Adv Pract Oncol 2020;11:159-167
  8. Gutierrez C, McEvoy C, Mead E, Stephens RS, Munshi L, Detsky ME, et al. Management of the critically ill adult chimeric antigen receptor-T cell therapy patient: a critical care perspective. Crit Care Med 2018;46:1402-1410 https://doi.org/10.1097/CCM.0000000000003258
  9. Rivera AM, May S, Lei M, Qualls S, Bushey K, Rubin DB, et al. CAR T-cell-associated neurotoxicity: current management and emerging treatment strategies. Crit Care Nurs Q 2020;43:191-204 https://doi.org/10.1097/CNQ.0000000000000302
  10. de Groot PM, Arevalo O, Shah K, Strange CD, Shroff GS, Ahuja J, et al. Imaging primer on chimeric antigen receptor T-cell therapy for radiologists. Radiographics 2022;42:176-194 https://doi.org/10.1148/rg.210065
  11. Yoon JG, Smith DA, Tirumani SH, Caimi PF, Ramaiya NH. CAR T-cell therapy: an update for radiologists. AJR Am J Roentgenol 2021;217:1461-1474 https://doi.org/10.2214/AJR.21.26091